Effects of Powered Hip Flexion Device in Persons With Multiple Sclerosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Dayton
About this trial
The purpose of this study is to assess the immediate effects of a commercially available non-FDA regulated powered hip flexion assist device (Hypershell X, Shenzhen, China) on walking ability in persons with MS. The main question it aims to answer is: Does a powered hip flexion device provide immediate improvements in walking ability over short distances for people with MS?
Eligibility criteria
Qualifiers
Age 18-80
Diagnosis of relapsing remitting, primary progressive or secondary progressive MS
Unilateral or bilateral hip flexion weakness (Manual muscle testing score of 3 or less)
Ability to walk at least 30 meters without requiring rest and without physical support or assistance from another person.
Disqualifiers
Prior regular use of a hip flexion orthosis within the past 6 months.
Cognitive or communication deficits that would limit ability to participate safely.
Significant pain or deformity of the lower extremities that could impact walking ability.
Severe spasticity (Modified Ashworth Score of 3 or 4) of the hips or lower extremities that could impact walking ability.
Trial design
Treatments tested in this trial
- Powered Hip Flexion Orthosis (Hypershell X)
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov